Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online November 1, 2007
Stem Cells Vol. 26 No. 2 February 2008, pp. 550 -561
doi:10.1634/stemcells.2007-0406; www.StemCells.com
© 2008 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2007-0406v1
2007-0406v2
26/2/550    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, C.-P.
Right arrow Articles by Yang, Y.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, C.-P.
Right arrow Articles by Yang, Y.-C.

TRANSLATIONAL AND CLINICAL RESEARCH

Trafficking of Multipotent Mesenchymal Stromal Cells from Maternal Circulation Through the Placenta Involves Vascular Endothelial Growth Factor Receptor-1 and Integrins

Chie-Pein Chena,b,c, Ming-Yi Leeb, Jian-Pei Huanga, John D. Aplind, Yi-Hsin Wub, Cing-Siang Hub, Pei-Chun Chenb, Hung Lie, Shiaw-Min Hwangf, Shu-Hsiang Liub, Yuh-Cheng Yangb

aDivision of High Risk Pregnancy and
bDepartment of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan;
cMackay Medicine, Nursing and Management College, Taipei, Taiwan;
dDivision of Human Development, Medical School, University of Manchester, Manchester, United Kingdom;
eInstitute of Molecular Biology, Academia Sinica, Taipei, Taiwan;
fBioresource Collection and Research Center, Food Industry Research and Development Institute, Hsinchu, Taiwan

Key Words. Integrins • Multipotent mesenchymal stromal cell • Microchimerism • Placenta Vascular endothelial growth factor receptor

Correspondence: Correspondence: Chie-Pein Chen, M.D., Ph.D., Division of High Risk Pregnancy, Mackay Memorial Hospital, 92 Sec. 2 Chung San North Road, Taipei 104, Taiwan Telephone: 011-886-2-2543-3535; Fax: 011-886-2-2754-3769; e-mail: cpchen{at}ms2.mmh.org.tw

Received on May 24, 2007; accepted for publication on October 23, 2007.

First published online in STEM CELLS EXPRESS  November 1, 2007.


Maternal cells can become engrafted in various fetal organs during pregnancy. The nature of the cells and the mechanisms of maternofetal cell trafficking are not clear. We demonstrate that human lineage-negative, CD34-negative (LinCD34) multipotent mesenchymal stromal cells express {alpha}2, {alpha}4, {alpha}5, and β1 integrins, which mediate their adhesion to endothelium, and vascular endothelial growth factor receptor-1 (VEGFR-1), which mediates their response to vascular endothelial growth factor A (VEGF-A). A maternal-fetal VEGF-A concentration gradient exists across the placental barrier, and cord blood plasma induces transendothelial and trans-Matrigel migration of stem cells in vitro. Migration is inhibited by a VEGF-A-neutralizing antibody or antibodies against VEGFR-1 or integrin {alpha}2, {alpha}4, {alpha}5, or β1. When LinCD34 multipotent mesenchymal stromal cells are transferred to rat maternal venous blood, they traffic through the placenta, engraft in various fetal organs, and persist in offspring for at least 12 weeks. Cell proliferation ability is retained in the xenogeneic placenta. Maternofetal trafficking is significantly reduced by blocking antibodies against integrins {alpha}2, {alpha}4, {alpha}5, and β1 or VEGFR-1. These results suggest that maternal microchimerism arises by the trafficking of multipotent mesenchymal stromal cells via VEGF-A- and integrin-dependent pathways across the hemochorial placenta to fetal tissues.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
Hum ReprodHome page
C.-P. Chen, S.-H. Liu, J.-P. Huang, J. D. Aplin, Y.-H. Wu, P.-C. Chen, C.-S. Hu, C.-C. Ko, M.-Y. Lee, and C.-Y. Chen
Engraftment potential of human placenta-derived mesenchymal stem cells after in utero transplantation in rats
Hum. Reprod., January 1, 2009; 24(1): 154 - 165.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2008 by AlphaMed Press.